Ana sayfa
Piyasalar
Grafikler ve fikirler
Algo
Haberler
Store
Aracı kurumlar
İndir
Ekonomik Takvim
Alım-satım sinyalleri
Web Terminali
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
ACXP
#4342
Acurx Pharmaceuticals, Inc. Common Stock
3.880
0
USD
-22.55%
Sektör:
Sağlık hizmetleri
Baz:
USD
Kar para birimi:
USD
Günlük aralık
Yıllık aralık
Günlük değişim
-22.55%
Aylık değişim
+102.08%
6 aylık değişim
+102.08%
Yıllık değişim
+102.08%
Önceki kapanış
5.010
0
Open
3.880
0
Bid
3.880
0
Ask
3.883
0
Low
3.880
0
High
3.880
0
Hacim
12
Piyasalar
ABD hisse senetleri
Sağlık hizmetleri
ACXP
Open full chart
Financials
Overview
Rapor
Statistics
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
844.63 K
1.1 M
1.17 M
1.58 M
2.09 M
2.86 M
—
Valuation ratios
Enterprise value
—
—
—
—
3.05 M
-447.09 K
—
Price to earnings ratio
—
—
—
—
-0.51
-0.47
—
Price to sales ratio
—
—
—
—
—
—
—
Price to cash flow ratio
—
—
—
—
-0.58
-0.55
—
Price to book ratio
—
—
—
—
0.52
0.71
—
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.47
-0.72
-0.45
-0.36
-0.33
-0.21
-1.34
Return on equity %
-1.06
-4.52
-0.93
-0.63
-0.55
-0.3
-2.41
Return on invested capital %
-188.34 K
-38.4 K
-29.73 K
—
-238.6 K
-193.4 K
—
Gross margin %
—
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
1.8
1.17
1.93
2.38
2.47
3.18
9.95
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
—
—
—
—
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-2.68
-2.78
-2.05
-1.4
-1.16
-0.79
-5.4
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
7.09
4.58
4.59
5.12
3.63
5.04
18.39
Net current asset value per share
7.31
4.7
4.8
5.17
3.75
5.13
18.85
Tangible book value per share
3.26
0.76
2.31
3
2.24
3.52
11.06
Working capital per share
3.26
0.69
2.31
3
2.23
3.52
11.05
Book value per share
3.26
0.76
2.31
3
2.24
3.52
11.06
Haberler
Acurx Pharmaceuticals, Inc. (ACXP) Q4 2025 Earnings Call Transcript
Acurx Pharmaceuticals 4Ç 2025 sonuçları: Nakit artışı ve Ar-Ge ilerlemesi
Earnings call transcript: Acurx Pharmaceuticals Q4 2025 reveals cash boost and R&D progress
Acurx Pharmaceuticals hisseleri yeni rCDI denemesiyle %3 kazandı
Acurx Pharmaceuticals stock gains over 3% on new rCDI trial launch
What's Going On With Acurx Pharmaceuticals Stock Today? - Acurx Pharmaceuticals (NASDAQ:ACXP)
Why Is Acurx Pharmaceuticals Stock Falling Thursday? - Acurx Pharmaceuticals (NASDAQ:ACXP)
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.61%
Why Is Acurx Pharmaceuticals Stock Up Over 105% Today? - Acurx Pharmaceuticals (NASDAQ:ACXP)
Has Acurx Pharmaceuticals (ACXP) Outpaced Other Medical Stocks This Year?
Acurx Pharmaceuticals, Inc. (ACXP) Q3 2025 Earnings Call Transcript
Acurx’ın ibezapolstat ilacı klinik deneylerde mikrobiyom koruyucu özellikler gösteriyor